29 May 2023 - Roche Canada today announced that it has successfully completed negotiations with the pan-Canadian Pharmaceutical Alliance for ...
26 May 2023 - The drug is approved in Australia to treat type 2 diabetes but people have flocked to it ...
26 May 2023 - If granted by the European Commission, Veklury will become the first and only authorised anti-viral treatment ...
26 May 2023 - Regulatory processes are continuing in other countries including the US. ...
26 May 2023 - Novo Nordisk today announced that the EMA's CHMP has adopted a positive opinion, recommending once weekly Sogroya ...
26 May 2023 - The EMA’s CHMP has recommended revoking the marketing authorisation for Adakveo (crizanlizumab), a medicine for preventing ...
26 May 2023 - Inpefa granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and ...
26 May 2023 - The European Commission decision is expected within 67 days of the CHMP opinion. ...
26 May 2023 - Ultomiris has the potential to eliminate relapses and redefine the treatment landscape for anti-aquaporin-4 (AQP4) antibody positive neuromyelitis ...
24 May 2023 - Europe relies on China for the production of certain key drugs such as antibiotics. ...
26 May 2023 - Recommendation based on results from the Phase 3 CheckMate-816 trial, in which Opdivo with chemotherapy demonstrated improved ...
26 May 2023 - The EMA’s CHMP recommended two medicines for approval at its May 2023 meeting. ...
25 May 2023 - PDUFA target action date set for 30 November 2023. ...
25 May 2023 - Amid concern that HIV prevention pills are not being widely taken by those at highest risk ...
25 May 2023 - The Librexia program evaluating milvexian is unrivaled as the most comprehensive factor XIa inhibitor clinical development ...